Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
Location: Home > Pharma China Web Edition > Regulatory News    
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
WiCON International Group
311 Sayre Drive,
Princeton, NJ 08540, USA
Tel/Fax: +1 702-9953905
Email:
info@pharmachinaonline.com

China Head Office
c/o Beijing Jicai PharmTech
Suite B-17D, Oriental Kenzo Plaza
48 Dongzhimenwai Dajie
Dongcheng District
Beijing 100027, China
Tel: +86 10 84476010
Fax: +86 10 84476010
Email:
info@pharmachinaonline.com
 
 
 
Regulatory News
 
CDE Solicits Public Comments for Clinical Research Guidelines for... 4/10/2020
CDE Solicits Public Comments for Clinical Research Guidelines for... 4/7/2020
CDE Solicits Public Comments for Clinical Research Guidelines for... 4/7/2020
NMPA Issues Announcement on Contemporary Drug Distribution Regula... 4/3/2020
NMPA Holds Teleconference for Major Drug Post-Marketing Regulator... 4/3/2020
CDE Solicits Public Comments for Clinical Research Guidelines for... 4/2/2020
NMPA Announcement on Implementation of the Amended Provisions for... 3/31/2020
NMPA Announcement on Implementation of the Amended Provisions for... 3/31/2020
Full English Translation - The Provisions on Registration of Drug... 3/31/2020
Full Translation: The Provisions for Control of Drug Manufacture 3/31/2020
SAMR Announces Its 2020 Legislation Plan 3/26/2020
NMPA Suspends Import, Sales and Use of Celgene's Paclitaxel for I... 3/25/2020
NIFDC Issues the 2019 National Drug Sample Inspection Annual Repo... 3/24/2020
NMPA Suspends Sales and Use of Supriya's Chlorphenamine Maleate F... 3/20/2020
CDE Publishes Two Draft Clinical Guidelines for R&D and Clinical ... 3/19/2020
NMPA Issues Five Standards for Essential Tracing Data Sets for MA... 3/11/2020
PhIRDA Proposes Policy Liberalization to Cope with Challenges Fac... 3/4/2020
NMPA Solicits Comments on Draft Guidelines for Quality Control Ag... 3/2/2020
NMPA Solicits Comments on Draft Working Procedures for Inspection... 3/2/2020
PhIRDA Advocates the Establishment of CEUA System for Drug Author... 2/26/2020
U.S. FDA Suspends China Inspections, Warns of Potential Shortages... 2/20/2020
WHO Posts New Procedure for Using Unapproved Drugs in Health Cris... 2/12/2020
NMPA Announces Implementation of Four Series Q ICH Guidelines in ... 1/21/2020
National Drug Registration and Post-marketing Surveillance Confer... 1/20/2020
NMPA Publicizes List of Reference Formulations for Generic Drug E... 1/20/2020
Review of Chinese Drug Registration Applications and Approvals in... 1/15/2020
NMPA Issues Notice on Matters Relating to API Registration Dossie... 1/13/2020
NMPA Publicizes List of Reference Formulations for Generic Drug E... 1/10/2020
NMPA Publicizes List of Reference Formulations for Generic Drug E... 1/10/2020
NMPA Deputy Commissioner Meets with PMDA Chief Executive 1/10/2020
Page:1/6    Total number of articles:172  :[1][2][3][4][5][>>][End]

 
 
 
 
© Wicon International Group  Support by: www.heightow.com   Site map | Contact Us | Links